Rifampin-induced bullous pemphigoid in tuberculosis treatment: A strategic rechallenge approach
This case underscores the complexity of managing drug-induced bullous pemphigoid in patients undergoing treatment for tuberculosis. The successful outcome was achieved through a cautious approach, including a rechallenge protocol and careful drug dose adjustments. The case offers valuable insights for clinicians managing similar complex presentations of drug-induced bullous pemphigoid, demonstrating that, with a tailored treatment strategy, both conditions can be effectively controlled.
Authors
- Munish Reddy (ORCID: https://orcid.org/0009-0003-2498-8420)
- Bhavana Doshi (ORCID: https://orcid.org/0000-0001-5630-6648)
- Pratiksha Kini
- V Shanbhag
- Vaishnavi V Gaonkar
Institutions
- KLE Academy of Higher Education and Research (IN)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1093/ajhp/zxaf218
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00